Heart Disease Trial, Recruiting NCT05097898 Sponsor: Central Hospital, Nancy, France Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT05097898
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with chronic heart failure where the heart's pumping function is still within normal range (a measurement of 50% or higher)
  • People who are admitted to hospital for a planned day visit or outpatient consultation related to their heart condition
  • People aged 18 years or older
  • People who have been fully informed about the study and have signed a consent form agreeing to take part
  • People who are covered by a French social security or health insurance scheme

Who may not be able to join:

  • People who have a serious illness where life expectancy is estimated to be 3 months or less
  • People who are currently receiving kidney dialysis (either peritoneal or haemodialysis), or whose kidneys are functioning at a very low level (confirm specific threshold with trial site)
  • People who have previously had surgery to remove part or all of a lung
  • People who have a serious lung or lining-of-the-lung condition (such as severe emphysema, chronic fluid around the lungs, or lung scarring) that would make ultrasound imaging of the lungs unreliable
  • People who are pregnant, in labour, or currently breastfeeding
  • People who are under a formal legal protection arrangement, such as guardianship or a similar court-appointed measure
  • People who are not able to give their own informed consent
  • People who are currently detained or have had their freedom restricted by a legal or administrative decision
  • People who are currently receiving compulsory psychiatric care under specific French public health law provisions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: + 33 3 83 15 73 22

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 August 2022
Est. completion
10 December 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Rate of death from all causes; Rate of hospitalisation for acute heart failure; Rate of day-hospital or in-home IV diuretics injection for acute HF

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov